Over 35 years of research and clinical use prove that hyperthermia works.
Hyperthermia therapy uses ultrasonic heat to weaken cancer cells and inhibit their ability to self-repair; in some cases, hyperthermia treatments destroy the cancer cells outright. Hyperthermia also works to eliminate tumors by increasing blood flow to the tumor, increasing blood flow and improving the oxygen levels that are able it, thereby enhancing the efficacy of radiation therapy (which works better in an oxygen-rich environment).
Hyperthermia heightens the power of radiation therapy and chemotherapy without adversely impacting healthy cells, which means patients only benefit from including hyperthermia therapy in their treatment plan. Over 35 years of research and clinical use of hyperthermia have never yielded proof of adverse effects on non-cancerous tissue.
Here at HCI, we know that learning about the details of cancer treatment can be overwhelming. It can be hard to even know where to start. Below, we list a selection of trusted studies that show how hyperthermia can amplify cancer treatment.
The addition of hyperthermia improves the likelihood of a complete response to breast cancer treatment more than radiation therapy alone.
When combined with radiation therapy, hyperthermia increases the likelihood of a complete response in cervical cancers by nearly 50%.
Overall survival rate at 5 years post-treatment of rectal cancer increased with the addition of hyperthermia.
Hyperthermia when combined with radiation therapy, increases the likelihood of a complete response in head and neck cancers.
Hyperthermia increases the likelihood of a complete response in melanoma cancers by upwards of 50% when combined with radiation therapy.
Breast Vernon CC et al. and van der Zee et al., Int. J. Radiation Oncology Biol. Phys. 1996; 35(4) 731-744 Head & Neck Valdagni et al., Int. J. Radiation Oncology Biol. Phys. 1994; 28: 163-169 Melanoma Overgaard J et al., Int. J. Hyperthermia 1996; 12(1): 3-20 Cervical van der Zee et al. Int. J. Hyperthermia 2002; 18(1): 1-12
